TetraLogic Pharmaceuticals Corporation
US ˙ OTCPK

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Nicholas Galakatos. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Nicholas Galakatos reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:ETTX / Entasis Therapeutics Holdings Inc Director 7,500
US:NSTG / NanoString Technologies, Inc. Director, 10% Owner 4,410
US:FTSV / Forty Seven, Inc. 10% Owner 0
US:HAIR / Restoration Robotics, Inc. 10% Owner 0
US:RDUS / Radius Recycling, Inc. 2,459,804
US:CATB / Astria Therapeutics Inc Director 6,500
US:TLOG / TetraLogic Pharmaceuticals Corporation 10% Owner 2,214,523
US:SIEN / Sientra, Inc. 10% Owner 5,461,530
US:OPHT / Ophthotech Corp Director 3,945
10% Owner 2,237,377
US:AERI / Aerie Pharmaceuticals Inc 10% Owner 0
Director 10,000
US:GMED / Globus Medical, Inc. 0
US:KBIO / KaloBios Pharmaceuticals, Inc. 10% Owner 0
US:SOMX / Somaxon Pharmaceuticals, Inc. 10% Owner 1,275,886
10% Owner 3
US:ZGNX / Zogenix Inc 10% Owner 9,482,439
US:AVNR / Avanir Pharmaceuticals Inc 10% Owner 12
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Nicholas Galakatos. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas TLOG / TetraLogic Pharmaceuticals Corporation - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em TLOG / TetraLogic Pharmaceuticals Corporation. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2013-12-17 TLOG Clarus Lifesciences II, L.P. 1,425,063 7.0000 1,425,063 7.0000 9,975,441 31 12.25 7,481,581 75.00

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

TLOG / TetraLogic Pharmaceuticals Corporation Insider Trades
Vendas Internas TLOG / TetraLogic Pharmaceuticals Corporation - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em TLOG / TetraLogic Pharmaceuticals Corporation. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2016-02-09 TLOG Clarus Lifesciences II, L.P. 230,507 0.1600 230,507 0.1600 36,881 317 0.0301 -29,943 -81.19
2016-02-08 TLOG Clarus Lifesciences II, L.P. 103,123 0.1900 103,123 0.1900 19,593
2016-02-05 TLOG Clarus Lifesciences II, L.P. 832,881 0.2000 832,881 0.2000 166,576
2016-02-04 TLOG Clarus Lifesciences II, L.P. 500,026 0.1400 500,026 0.1400 70,004
2016-02-03 TLOG Clarus Lifesciences II, L.P. 82,583 0.1500 82,583 0.1500 12,387
2016-02-02 TLOG Clarus Lifesciences II, L.P. 176,306 0.1700 176,306 0.1700 29,972
2016-02-01 TLOG Clarus Lifesciences II, L.P. 140,000 0.2000 140,000 0.2000 28,000
2016-01-29 TLOG Clarus Lifesciences II, L.P. 52,826 0.2600 52,826 0.2600 13,735
2016-01-28 TLOG Clarus Lifesciences II, L.P. 32,521 0.2600 32,521 0.2600 8,455
2016-01-27 TLOG Clarus Lifesciences II, L.P. 209,984 0.2700 209,984 0.2700 56,696
2016-01-26 TLOG Clarus Lifesciences II, L.P. 69,425 0.3000 69,425 0.3000 20,828

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

TLOG / TetraLogic Pharmaceuticals Corporation Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Nicholas Galakatos conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2019-06-21 2019-06-19 4 ETTX Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
A - Award 7,500 7,500
2019-03-27 2019-03-25 4 NSTG NanoString Technologies Inc
Common Stock
A - Award 4,410 4,410
2019-01-22 2019-01-18 4 ETTX Entasis Therapeutics Holdings Inc.
Stock Option (right to buy)
A - Award 15,000 15,000
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche B Convertible Preferred Stock
C - Conversion -8,552,024 0 -100.00
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B-1 Tranche A Convertible Preferred Stock
C - Conversion -6,702,213 0 -100.00
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Series B Convertible Preferred Stock
C - Conversion -7,500,000 0 -100.00
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
P - Purchase 453,395 1,623,405 38.75 15.00 6,800,925 24,351,075
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
C - Conversion 412,583 1,170,010 54.47
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
C - Conversion 323,341 685,170 89.36
2018-10-02 2018-09-28 4 ETTX Entasis Therapeutics Holdings Inc.
Common Stock
C - Conversion 361,829 361,829
2018-09-19 2018-09-17 4 NSTG NanoString Technologies Inc
Common Stock Warrant (Right to Buy)
X - Other -162,408 0 -100.00
2018-09-19 2018-09-17 4 NSTG NanoString Technologies Inc
Common Stock
S - Sale -85,823 4,036,025 -2.08 15.99 -1,372,310 64,536,040
2018-09-19 2018-09-17 4 NSTG NanoString Technologies Inc
Common Stock
X - Other 162,408 4,121,848 4.10 8.45 1,372,023 34,821,372
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series B Preferred Stock
C - Conversion -1,922,682 0 -100.00
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-2 Preferred Stock
C - Conversion -755,780 0 -100.00
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Series A-1 Preferred Stock
C - Conversion -938,489 0 -100.00
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
P - Purchase 200,000 3,816,951 5.53 16.00 3,200,000 61,071,216
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
C - Conversion 1,922,682 3,616,951 113.48
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
C - Conversion 755,780 1,694,269 80.53
2018-07-02 2018-07-02 4 FTSV Forty Seven, Inc.
Common Stock
C - Conversion 938,489 938,489
2018-01-03 2018-01-01 4 NSTG NanoString Technologies Inc
Common Stock
A - Award 10,168 10,168
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Series C Preferred Stock
C - Conversion -3,389,105 0 -100.00
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Convertible Promissory Note
C - Conversion 0
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock
C - Conversion 180,881 3,569,986 5.34 7.00 1,266,167 24,989,902
2017-10-17 2017-10-16 4 HAIR Restoration Robotics Inc
Common Stock
C - Conversion 3,389,105 3,389,105
2017-10-13 2017-10-11 4 HAIR Restoration Robotics Inc
Convertible Promissory Note
J - Other 1,259,269.79
2017-01-04 2017-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 8,611 8,611
2016-09-29 2016-09-27 4 RDUS Radius Health, Inc.
Common Stock
J - Other -1,229,902 2,459,804 -33.33
2016-08-05 2016-08-03 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 6,500 6,500
2016-02-10 2016-02-09 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -230,507 2,214,523 -9.43 0.16 -36,881 354,324
2016-02-10 2016-02-08 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -103,123 2,445,030 -4.05 0.19 -19,593 464,556
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-09 3 SIEN Sientra, Inc.
Common Stock
5,461,530
2016-02-05 2016-02-05 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -832,881 2,548,153 -24.63 0.20 -166,576 509,631
2016-02-05 2016-02-04 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -500,026 3,381,034 -12.88 0.14 -70,004 473,345
2016-02-05 2016-02-03 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -82,583 3,881,060 -2.08 0.15 -12,387 582,159
2016-02-02 2016-02-02 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -176,306 3,963,643 -4.26 0.17 -29,972 673,819
2016-02-02 2016-02-01 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -140,000 4,139,949 -3.27 0.20 -28,000 827,990
2016-02-02 2016-01-29 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -52,826 4,279,949 -1.22 0.26 -13,735 1,112,787
2016-01-28 2016-01-28 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -32,521 4,332,775 -0.74 0.26 -8,455 1,126,522
2016-01-28 2016-01-27 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -209,984 4,365,296 -4.59 0.27 -56,696 1,178,630
2016-01-28 2016-01-26 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
S - Sale -69,425 4,575,280 -1.49 0.30 -20,828 1,372,584
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -499 3,945 -11.23 65.33 -32,600 257,727
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -501 4,444 -10.13 65.45 -32,790 290,860
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1,001 5,684 -14.97 66.33 -66,396 377,020
2016-01-13 2016-01-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -999 6,685 -13.00 65.45 -65,385 437,533
2016-01-05 2016-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 7,828 7,828
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -733 4,945 -12.91 64.63 -47,374 319,595
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -267 5,678 -4.49 63.91 -17,064 362,881
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1,467 7,684 -16.03 64.63 -94,812 496,617
2015-12-14 2015-12-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -533 9,151 -5.50 63.90 -34,059 584,749
2015-11-19 2015-11-18 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 5,945 -7.76 60.00 -30,000 356,700
2015-11-19 2015-11-18 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1,000 9,684 -9.36 60.00 -60,000 581,040
2015-11-12 2015-11-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 6,445 -7.20 58.69 -29,345 378,257
2015-11-12 2015-11-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1,000 10,684 -8.56 58.69 -58,690 627,044
2015-11-12 2015-11-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 6,945 -6.72 60.00 -30,000 416,700
2015-11-12 2015-11-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1,000 11,684 -7.88 60.00 -60,000 701,040
2015-11-04 2015-11-02 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -500 7,445 -6.29 54.00 -27,000 402,030
2015-11-04 2015-11-02 4 OPHT Ophthotech Corp.
Common Stock
S - Sale X -1,000 13,184 -7.05 54.00 -54,000 711,936
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 11,094 11,094
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -9,728,971 0 -100.00
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -20,800,000 0 -100.00
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Common Stock
P - Purchase 376,695 2,752,488 15.86 12.00 4,520,340 33,029,856
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Common Stock
C - Conversion 757,117 2,375,793 46.77
2015-06-30 2015-06-30 4 CATB CATABASIS PHARMACEUTICALS INC
Common Stock
C - Conversion 1,618,676 1,618,676
2015-06-29 2015-06-12 4 OPHT Ophthotech Corp.
Common Stock
G - Gift -1,020 14,184 -6.71
2015-06-17 2015-06-16 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -39,701 2,237,377 -1.74 14.30 -567,724 31,994,491
2015-06-17 2015-06-15 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -1,529 2,277,078 -0.07 14.27 -21,819 32,493,903
2015-06-12 2015-06-12 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -6,430 2,278,607 -0.28 14.25 -91,628 32,470,150
2015-06-12 2015-06-11 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -25,168 2,285,037 -1.09 14.27 -359,147 32,607,478
2015-06-10 2015-06-10 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -8,987 2,310,205 -0.39 14.32 -128,694 33,082,136
2015-06-10 2015-06-09 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -13,000 2,319,192 -0.56 14.26 -185,380 33,071,678
2015-06-10 2015-06-08 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -2,662 2,332,192 -0.11 14.25 -37,934 33,233,736
2015-06-08 2015-06-04 4 OPHT Ophthotech Corp.
Restricted Stock Units
A - Award 1,750 1,750
2015-06-08 2015-06-04 4 OPHT Ophthotech Corp.
Stock Option (Right To Buy)
A - Award 7,000 7,000
2015-06-03 2015-06-03 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -10,450 2,334,854 -0.45 14.32 -149,644 33,435,109
2015-06-03 2015-06-02 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -11,014 2,345,304 -0.47 14.25 -156,950 33,420,582
2015-06-03 2015-06-01 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -15,010 2,356,318 -0.63 14.29 -214,493 33,671,784
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other -1,554,744 0 -100.00
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other 3,137 7,945 65.25
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other 7,319 15,204 92.82
2015-05-28 2015-05-26 4 OPHT Ophthotech Corp.
Common Stock
J - Other -1,554,744 0 -100.00
2015-03-24 2015-03-23 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -26,300 2,371,328 -1.10 14.44 -379,772 34,241,976
2015-03-24 2015-03-20 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -27,115 2,397,628 -1.12 14.53 -393,981 34,837,535
2015-03-19 2015-03-19 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -50,012 2,424,743 -2.02 14.61 -730,675 35,425,495
2015-03-19 2015-03-18 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -25,000 2,474,755 -1.00 14.68 -367,000 36,329,403
2015-03-19 2015-03-17 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
S - Sale -79,307 2,499,755 -3.08 14.67 -1,163,434 36,671,406
2015-01-30 2015-01-28 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
J - Other -3,139,447 0 -100.00
2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock Warrant
C - Conversion 184,812 0 -100.00
2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Series B Preferred Warrant
C - Conversion -184,812 0 -100.00
2015-01-30 2013-10-25 4/A AERI AERIE PHARMACEUTICALS INC
Common Stock
P - Purchase 321,000 3,468,494 10.20 10.00 3,210,000 34,684,940
2015-01-12 2015-01-08 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -175,000 3,324,259 -5.00 31.11 -5,444,250 103,417,697
2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -10,200 3,499,259 -0.29 31.11 -317,322 108,861,947
2015-01-06 2015-01-05 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -13,420 3,509,459 -0.38 30.67 -411,591 107,635,108
2015-01-05 2015-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 7,307 7,307
2014-12-30 2014-12-29 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -6,214 3,522,879 -0.18 30.03 -186,606 105,792,056
2014-12-30 2014-12-26 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -74,510 3,529,093 -2.07 30.05 -2,239,026 106,049,245
2014-12-24 2014-12-23 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -263 3,603,603 -0.01 30.00 -7,890 108,108,090
2014-12-24 2014-12-22 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
S - Sale -49,441 3,603,866 -1.35 30.36 -1,501,029 109,413,372
2014-07-01 2014-06-27 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 10,000 10,000
2014-06-18 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
J - Other 2,308 4,808 92.32 44.24 102,104 212,701
2014-06-18 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
J - Other 5,385 7,885 215.40 44.24 238,227 348,825
2014-06-18 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
J - Other -1,143,844 1,554,744 -42.39 44.24 -50,602,515 68,780,320
2014-06-16 2014-06-11 4 AERI AERIE PHARMACEUTICALS INC
Option (right to buy)
A - Award 13,500 13,500
2014-06-16 2014-06-16 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -15,482 2,698,588 -0.57 44.00 -681,208 118,737,872
2014-06-16 2014-06-13 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -82,277 2,714,070 -2.94 44.01 -3,621,225 119,453,277
2014-06-16 2014-06-12 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -47,217 2,796,347 -1.66 44.51 -2,101,657 124,467,083
2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -500 4,500 -10.00 44.32 -22,160 199,440
2014-06-11 2014-06-11 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -29,217 2,843,564 -1.02 44.53 -1,301,074 126,627,886
2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -200 2,872,781 -0.01 46.80 -9,360 134,446,151
2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -36,880 2,872,981 -1.27 45.90 -1,692,630 131,857,187
2014-06-11 2014-06-10 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -79,824 2,909,861 -2.67 44.66 -3,564,988 129,956,138
2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -39,362 2,989,685 -1.30 46.78 -1,841,500 139,868,526
2014-06-11 2014-06-09 4 OPHT Ophthotech Corp.
Common Stock
S - Sale -25,697 3,029,047 -0.84 46.02 -1,182,463 139,383,415
2014-06-11 2014-06-10 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
S - Sale -404 0 -100.00 23.36 -9,437
2014-06-11 2014-06-10 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
S - Sale -965 0 -100.00 23.36 -22,542
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series B Convertible Preferred
C - Conversion -91,175 0 -100.00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-3 Convertible Preferred Stock
C - Conversion -53,331 0 -100.00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-2 Convertible Preferred Stock
C - Conversion -217,873 0 -100.00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Series A-1 Convertible Preferred Stock
C - Conversion -269,724 0 -100.00
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
J - Other 694,449 3,689,706 23.18
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 399,891 2,995,257 15.41
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 255,881 2,595,366 10.94
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 1,045,351 2,339,485 80.78
2014-06-10 2014-06-06 4 RDUS Radius Health, Inc.
Common Stock
C - Conversion 1,294,134 1,294,134
2014-05-23 2014-05-21 4 OPHT Ophthotech Corp.
Director Stock Options (Right to Buy)
A - Award 15,000 15,000
2014-03-27 2014-02-26 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
J - Other 404 404
2014-03-27 2014-02-26 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
J - Other 965 965
2014-01-03 2014-01-01 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 5,847 5,847
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Warrants
X - Other -23,282 0 -100.00 6.40 -149,056
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Convertible Notes
C - Conversion -853,416 0 -100.00
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
C - Conversion -2,342,944 0 -100.00
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
X - Other 23,282 4,644,705 0.50 6.40 149,056 29,736,330
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
C - Conversion 853,416 4,621,423 22.65 7.00 5,973,912 32,349,961
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
C - Conversion 2,342,944 3,768,007 164.41
2013-12-19 2013-12-17 4 TLOG TETRALOGIC PHARMACEUTICALS CORP
Common Stock
P - Purchase 1,425,063 1,425,063 7.00 9,975,441 9,975,441
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series G Preferred Ordinary Shares
C - Conversion -203,439 0 -100.00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series F Preferred Ordinary Shares
C - Conversion -553,859 0 -100.00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Series E Preferred Ordinary Shares
C - Conversion -1,239,308 0 -100.00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion -582,456 0 -100.00
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 203,439 2,579,062 8.56
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 553,859 2,375,623 30.40
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 1,239,308 1,821,764 212.77
2013-11-25 2013-11-22 4 OXFD Oxford Immunotec Global PLC
Ordinary Shares
C - Conversion 582,456 582,456
2013-11-20 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
P - Purchase 2,500 2,500 22.00 55,000 55,000
2013-11-20 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
P - Purchase 2,500 2,500 22.00 55,000 55,000
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Convertible Notes
C - Conversion -420,222 0 -100.00
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Warrants
C - Conversion -184,812 0 -100.00
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Series B Convertible Preferred Stock
C - Conversion -2,727,272 0 -100.00
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
P - Purchase 321,000 3,653,306 9.63 10.00 3,210,000 36,533,060
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
C - Conversion 184,812 3,332,306 5.87 0.05 9,241 166,615
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
C - Conversion 420,222 3,147,494 15.41
2013-10-28 2013-10-25 4 AERI AERIE PHARMACEUTICALS INC
Common Stock
C - Conversion 2,727,272 2,727,272
2013-10-25 2013-10-23 4 OPHT Ophthotech Corp.
Stock Option (Right to Buy)
A - Award 22,033 22,033
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series C Preferred Stock
C - Conversion -186,027 0 -100.00
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Series B Preferred Stock
C - Conversion -2,542,373 0 -100.00
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
C - Conversion 186,027 2,728,390 7.32
2013-10-02 2013-09-30 4 OPHT Ophthotech Corp.
Common Stock
C - Conversion 2,542,373 2,542,373
2013-09-04 2013-09-03 4 GMED GLOBUS MEDICAL INC
Class A Common Stock
J - Other -7,244,201 0 -100.00
2013-07-12 2013-07-10 4 NSTG NanoString Technologies Inc
Stock Option (Right to Buy)
A - Award 8,768 8,768
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock Warrant (Right to Buy)
C - Conversion 162,408 162,408 8.45 1,372,348 1,372,348
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series D Preferred Warrant (Right to Buy)
C - Conversion -162,408 0 -100.00 8.45 -1,372,348
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series E Preferred Stock
C - Conversion -148,342 0 -100.00
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series D Preferred Stock
C - Conversion -812,045 0 -100.00
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Series C Preferred Stock
C - Conversion -2,249,053 0 -100.00
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
A - Award 750,000 3,959,440 23.37 10.00 7,500,000 39,594,400
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
C - Conversion 148,342 3,209,440 4.85
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
C - Conversion 812,045 3,061,098 36.11
2013-07-01 2013-07-01 4 NSTG NanoString Technologies Inc
Common Stock
C - Conversion 2,249,053 2,249,053
2013-06-07 2013-06-05 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 14,101 14,101
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -120,566 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -8,106 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -3,641 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -10,189 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -2,334 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -550,530 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -37,016 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -16,625 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -46,526 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -10,658 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -553,204 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -37,196 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -16,707 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -46,752 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -10,710 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -807,939 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -54,323 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -24,400 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -68,280 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -15,642 0 -100.00
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 2,032,239 2,032,239
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 136,641 136,641
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 61,373 61,373
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 171,747 171,747
2013-05-30 2013-05-28 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
C - Conversion 39,344 39,344
2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Common Stock Warrant
P - Purchase 227,939 0 -100.00 6.14 1,400,001
2013-04-30 2013-04-23 4 RDUS Radius Health, Inc.
Series B Convertible Preferred Stock
P - Purchase 91,175 0 -100.00 61.42 5,599,968
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -275,539 0 -100.00
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -337,622 0 -100.00
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Series B-2 Preferred Stock
C - Conversion -1,949,879 0 -100.00
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock
C - Conversion 313,527 2,632,928 13.52
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock
C - Conversion 369,522 2,319,401 18.95
2013-02-07 2013-02-05 4 KBIO KALOBIOS PHARMACEUTICALS INC
Common Stock
C - Conversion 1,949,879 1,949,879
2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Series E Preferred Stock
C - Conversion -7,444,168 0 -100.00
2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock
S - Sale -804,232 7,244,201 -9.99 11.16 -8,975,229 80,845,283
2012-08-10 2012-08-08 4 GMED GLOBUS MEDICAL INC
Class A Common Stock
C - Conversion 7,444,168 8,048,433 1,231.94
2012-08-02 3 GMED GLOBUS MEDICAL INC
Class A Common Stock
604,265
2012-07-10 2012-07-09 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -1,624,574 1,275,886 -56.01 0.31 -498,744 391,697
2012-07-10 2012-07-06 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -671,217 2,900,460 -18.79 0.29 -195,324 844,034
2012-07-05 2012-07-03 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -98,210 3,571,677 -2.68 0.29 -28,481 1,035,786
2012-07-05 2012-07-02 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -80,348 3,669,887 -2.14 0.29 -23,301 1,064,267
2012-07-02 2012-06-28 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -19,500 3,750,235 -0.52 0.29 -5,655 1,087,568
2012-06-21 2012-06-19 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -12,000 3,759,735 -0.32 0.29 -3,480 1,090,323
2012-06-19 2012-06-15 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -1,450 3,781,735 -0.04 0.29 -420 1,096,703
2012-06-07 2012-06-06 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -8,400 3,783,185 -0.22 0.29 -2,436 1,097,124
2012-06-07 2012-06-05 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -29,555 3,791,585 -0.77 0.29 -8,571 1,099,560
2012-06-06 2012-06-04 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
J - Other -10,942,468 3 -100.00
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy)
X - Other -1,290,922 0 -100.00
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock Warrant (right to buy)
X - Other -1,706,426 0 -100.00
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -708,810 10,942,471 -6.08 7.49 -5,311,255 81,994,124
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
S - Sale -608,146 11,651,281 -4.96 7.49 -4,556,960 87,305,379
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
X - Other 1,706,426 12,259,427 16.17 3.11 5,311,251 38,157,467
2012-06-04 2012-05-31 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
X - Other 1,290,922 10,553,001 13.94 3.53 4,556,955 37,252,094
2012-06-04 2012-05-31 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -29,850 3,821,140 -0.78 0.30 -8,955 1,146,342
2012-06-04 2012-05-30 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -51,007 3,850,990 -1.31 0.30 -15,302 1,155,297
2012-06-04 2012-05-29 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -15,300 3,901,997 -0.39 0.30 -4,622 1,178,793
2012-06-04 2012-05-25 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -293,015 3,917,297 -6.96 0.30 -87,904 1,175,189
2012-06-04 2012-05-23 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -135,250 4,210,312 -3.11 0.30 -40,629 1,264,778
2012-06-04 2012-05-22 4 SOMX Somaxon Pharmaceuticals, Inc.
Common Stock
S - Sale -287,000 4,345,562 -6.20 0.30 -86,990 1,317,140
2011-09-20 2011-09-16 4 ZGNX ZOGENIX, INC.
Common Stock
P - Purchase 3,500,000 9,482,439 58.50 2.00 7,000,000 18,964,878
2010-12-07 2010-12-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
J - Other -6,669,204 12 -100.00
2010-11-10 2010-11-09 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,200,000 6,669,216 -15.25 4.81 -5,773,920 32,089,600
2010-11-10 2010-11-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -44,626 7,869,216 -0.56 5.10 -227,593 40,133,002
2010-11-05 2010-11-05 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -332,572 7,913,842 -4.03 4.80 -1,597,377 38,010,975
2010-11-05 2010-11-03 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,400,106 8,246,414 -14.51 4.52 -6,332,539 37,297,706
2010-11-02 2010-11-02 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,290,871 9,646,520 -11.80 4.49 -5,800,400 43,345,673
2010-11-02 2010-11-01 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,478,142 10,937,391 -18.47 5.36 -13,273,424 58,582,854
2010-11-02 2010-10-29 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,424,947 13,415,533 -9.60 5.06 -7,215,647 67,933,576
2010-10-12 2010-10-11 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -311,000 14,840,480 -2.05 3.52 -1,093,445 52,177,644
2010-10-12 2010-10-08 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -240,838 15,151,480 -1.56 3.47 -836,792 52,643,817
2010-07-15 2010-07-13 4 AVNR AVANIR PHARMACEUTICALS, INC.
Common Stock
S - Sale -165,000 15,392,318 -1.06 3.53 -583,143 54,399,530
2008-04-11 3 AVNR AVANIR PHARMACEUTICALS
Class A Common Stock
15,557,318
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)